Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nan-Xiang Chen, Fei-Fan Zhao, Fang Yan & Xin-Xin Zhang. (2016) Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment. Acta Oto-Laryngologica 136:2, pages 177-180.
Read now
Read now
Articles from other publishers (29)
Mark Edward Jao, Amy Ly Indorf, Eve-Michelle Segal, Abby Miske, Keith David Eaton, Trisha Marsolini & Simran Ghuman. (2023) Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions. Journal of Oncology Pharmacy Practice, pages 107815522311685.
Crossref
Crossref
Marissa Ryan, Centaine Snoswell & Christine Carrington. (2022) Is the use of ranitidine required as a pre‐medication to prevent hypersensitivity reactions to paclitaxel?. Journal of Pharmacy Practice and Research 52:1, pages 53-58.
Crossref
Crossref
Olivia M. Lansinger, Savanna Biedermann, Zihuai He & A. Dimitrios Colevas. (2021) Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions. Journal of Clinical Oncology 39:32, pages 3583-3590.
Crossref
Crossref
Romualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, Jiani Hu, Tianyu Li, Rebecca Rees, Natalie Sinclair, Lindsey Milisits, Jose Pablo Leone, Michael Constantine, Meredith Faggen, Frederick Briccetti, Caroline Block, Ann Partridge, Harold Burstein, Adrienne G. Waks, Nabihah Tayob, Lorenzo Trippa, Sara M. Tolaney, Michael J. Hassett, Eric P. Winer & Nancy U. Lin. (2021) Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer. The Oncologist 26:11, pages 927-933.
Crossref
Crossref
Maryam Sheybanifard, Nataliia Beztsinna, Mahsa Bagheri, Eva Miriam Buhl, Jaleesa Bresseleers, Aida Varela-Moreira, Yang Shi, Cornelus F. van Nostrum, Gabri van der Pluijm, Gert Storm, Wim E. Hennink, Twan Lammers & Josbert M. Metselaar. (2020) Systematic evaluation of design features enables efficient selection of Π electron-stabilized polymeric micelles. International Journal of Pharmaceutics 584, pages 119409.
Crossref
Crossref
Nicola Longo, David Dimmock, Harvey Levy, Krista Viau, Heather Bausell, Deborah A. Bilder, Barbara Burton, Christel Gross, Hope Northrup, Fran Rohr, Stephanie Sacharow, Amarilis Sanchez-Valle, Mary Stuy, Janet Thomas, Jerry Vockley, Roberto Zori & Cary O. Harding. (2019) Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genetics in Medicine 21:8, pages 1851-1867.
Crossref
Crossref
Ana Luísa de Castro Baccarin, Macilon Nonato Irene, Daniel de Iracema Gomes Cubero, Ariana Sales Luz, Suelen Nastri Castro, Renan Sordi, Luis Eduardo Silva Móz & Auro Del Giglio. (2018) The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients. Supportive Care in Cancer 27:3, pages 927-931.
Crossref
Crossref
Marianna M. Henry & Terry L. Noah. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
876
885.e6
.
Napa Parinyanitikul, Walailuk Tanpipattanakul, Nattaya Poovorawan, Thanapoom Rattananupong, Poranee Laoitthi, Piyada Sithidetphaiboon, Suebpong Thanasanvimon & Virote Sriuranpong. (2018) Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy. Supportive Care in Cancer 26:7, pages 2471-2477.
Crossref
Crossref
Ayberk Yenilmez, Annette P Hood, Lien H Nguyen & Man Y Merl. (2016) Paclitaxel pre-medication: A comparison of two steroid pre-medication protocols. Journal of Oncology Pharmacy Practice 23:7, pages 491-495.
Crossref
Crossref
Jenny Furlanetto, Christian Jackisch, Michael Untch, Andreas Schneeweiss, Sabine Schmatloch, Bahriye Aktas, Carsten Denkert, Hermann Wiebringhaus, Sherko Kümmel, Mathias Warm, Stefan Paepke, Marianne Just, Claus Hanusch, John Hackmann, Jens Uwe Blohmer, Michael Clemens, Serban Dan Costa, Bernd Gerber, Valentina Nekljudova, Sibylle Loibl & Gunter von Minckwitz. (2017) Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69). Breast Cancer Research and Treatment 163:3, pages 495-506.
Crossref
Crossref
Hiroshi Nokihara, Noboru Yamamoto, Yuichiro Ohe, Masaki Hiraoka & Tomohide Tamura. (2016) Pharmacokinetics of Weekly Paclitaxel and Feasibility of Dexamethasone Taper in Japanese Patients with Advanced Non?small Cell Lung Cancer. Clinical Therapeutics 38:2, pages 338-347.
Crossref
Crossref
Matthieu Picard & Mariana C. Castells. (2014) Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review. Clinical Reviews in Allergy & Immunology 49:2, pages 177-191.
Crossref
Crossref
Michael J. Berger, Craig Vargo, Mary Vincent, Katy Shaver, Gary Phillips, Rachel Layman, Erin Macrae, Ewa Mrozek, Bhuvaneswari Ramaswamy, Robert Wesolowski, Charles L. Shapiro & Maryam B. Lustberg. (2014) Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction. Supportive Care in Cancer 23:7, pages 2019-2024.
Crossref
Crossref
Ka-Eun Yoo, Rae Young Kang, Ju-Yeun Lee, Yu Jeung Lee, Sung Yun Suh, Kwi Suk Kim, Hyang Sook Kim, Se-Hoon Lee & Byung Koo Lee. (2014) Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy. Supportive Care in Cancer 23:7, pages 1969-1977.
Crossref
Crossref
Wenjing Hou, Jianhua Guan, Huan Lu, Qian Dong, Yuhong Han & Rong Zhang. (2014) RETRACTED ARTICLE: The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel. Journal of Ovarian Research 7:1.
Crossref
Crossref
Michael J. Berger, Leslie J. Dunlea, Amy E. Rettig, Maryam B. Lustberg, Gary S. Phillips & Charles L. Shapiro. (2011) Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction. Supportive Care in Cancer 20:9, pages 1991-1997.
Crossref
Crossref
Joanna R Schwartz. (2011) Dexamethasone premedication for prophylaxis of taxane toxicities: Can the doses be reduced when paclitaxel or docetaxel are given weekly?. Journal of Oncology Pharmacy Practice 18:2, pages 250-256.
Crossref
Crossref
Marianna M. Henry & Terry L. Noah. 2012. Kendig & Chernickâs Disorders of the Respiratory Tract in Children. Kendig & Chernickâs Disorders of the Respiratory Tract in Children
1026
1035
.
Lincy S. Lal, Donna L. Gerber, Jason Lau & William Dana. (2009) Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center. Supportive Care in Cancer 17:10, pages 1311-1315.
Crossref
Crossref
Jamal Zidan, O. Hussein, A. Abzah, S. Tamam, Z. Farraj & E. Friedman. (2008) Oral premedication for the prevention of hypersensitivity reactions to paclitaxel. Medical Oncology 25:3, pages 274-278.
Crossref
Crossref
I Leonard Bernstein, James T. Li, David I. Bernstein, Robert Hamilton, Sheldon L. Spector, Ricardo Tan, Scott Sicherer, David B.K. Golden, David A. Khan, Richard A. Nicklas, Jay M. Portnoy, Joann Blessing-Moore, Linda Cox, David M. Lang, John Oppenheimer, Christopher C. Randolph, Diane E. Schuller, Stephen A. Tilles, Dana V. Wallace, Estelle Levetin & Richard Weber. (2008) Allergy Diagnostic Testing: An Updated Practice Parameter. Annals of Allergy, Asthma & Immunology 100:3, pages S1-S148.
Crossref
Crossref
Brett L. Buchmiller & David A. Khan. (2008) Evaluation and management of pediatric drug allergic reactions. Current Allergy and Asthma Reports 7:6, pages 402-409.
Crossref
Crossref
Henry Wang, Janice Ryu, David Gandara, Richard J. Bold, Shiro Urayama, Michael Tanaka, Zelanna Goldberg, David Follette, Samir Narayan & Derick Lau. (2007) A Phase II Study of Paclitaxel, Carboplatin, and Radiation with or without Surgery for Esophageal Cancer. Journal of Thoracic Oncology 2:2, pages 153-157.
Crossref
Crossref
Agnes Henry, Bruno Charpiat, Maurice Perol, Thierry Vial, Pierre Jousselin de Saint Hilaire & Jacques Descotes. (2006) Paclitaxel Hypersensitivity Reactions. The Cancer Journal 12:3, pages 237-245.
Crossref
Crossref
Marianna M. Henry & Terry L. Noah. 2006. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
1000
1013
.
Albert S. Braverman, Sujatha Rao, Mary Ellen Salvatti, Barbara Adamson, Margaret McManus & Shirley Pierre. (2005) Tapering and Discontinuation of Glucocorticoid Prophylaxis during Prolonged Weekly to Biweekly Paclitaxel Administration. Chemotherapy 51:2-3, pages 116-119.
Crossref
Crossref
Jessica C. Karl & Crystal L. Mackall. 2005.
325
341
.
Stuart Murray, Ivan Simmons & Craig James. (2003) Cutaneous angiosarcoma of the face and scalp presenting as alopecia. Australasian Journal of Dermatology 44:4, pages 273-276.
Crossref
Crossref